Cargando…

Cobrotoxin could be an effective therapeutic for COVID-19

Detalles Bibliográficos
Autores principales:	Lin, Fang, Reid, Paul F., Qin, Zheng-hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445445/ https://www.ncbi.nlm.nih.gov/pubmed/32843715 http://dx.doi.org/10.1038/s41401-020-00501-7

Ejemplares similares

Author Correction: Cobrotoxin could be an effective therapeutic for COVID-19
por: Lin, Fang, et al.
Publicado: (2020)

Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats
por: Wang, Shu-Zhi, et al.
Publicado: (2015)

Antitumor activity of cobrotoxin in human lung adenocarcinoma A549 cells and following transplantation in nude mice
por: SHEN, JIAN, et al.
Publicado: (2014)

The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
por: Ribeiro, Sandro Augusto, et al.
Publicado: (2020)

Compromised periodontal status could increase mortality for patients with COVID-19
por: Gupta, Shipra, et al.
Publicado: (2022)

How NETosis could drive “Post-COVID-19 syndrome” among survivors
por: Sawadogo, Serge A., et al.
Publicado: (2020)

Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2022)

Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
por: Nayak, Saurabh, et al.
Publicado: (2021)

The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response
por: Madad, Syra, et al.
Publicado: (2021)

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

WHO COVID-19 therapeutic guidelines
por: Rochwerg, Bram, et al.
Publicado: (2021)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London
por: Alhashmi, A., et al.
Publicado: (2021)

The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023)

Re: COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. A reply
por: Adam, E.J., et al.
Publicado: (2021)

Therapeutic Application of Alpha-1 Antitrypsin in COVID-19
por: Ritzmann, Felix, et al.
Publicado: (2021)

WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)

Could SARS-CoV-2 cause tauopathy?
por: Pratt, James, et al.
Publicado: (2021)

Divergent vaccination policies could fuel mistrust and hesitancy
por: Forman, Rebecca, et al.
Publicado: (2021)

Neurological Abnormality Could be the First and Only Symptom of Familial Hemophagocytic Lymphohistiocytosis: Report of Two Families
por: Zhao, Yun-Ze, et al.
Publicado: (2018)

COVID-19 complicated by acute arterial thrombosis: Therapeutic challenges
por: Shereef, Hammam, et al.
Publicado: (2020)

Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome
por: Gupta, Sandeep, et al.
Publicado: (2020)

Morganella morganii could be an important Intensive Care Unit pathogen
por: Singla, Nidhi, et al.
Publicado: (2010)

Addressing Africa’s outrageous neurosurgeons deficit: what could the problem be?
por: Wireko, Andrew A., et al.
Publicado: (2023)

Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program
por: Cámara, Ana, et al.
Publicado: (2021)

Could the Adriatic islands of Croatia be heading in the same direction as the Canary Islands?
por: Brož, Jan, et al.
Publicado: (2019)

How medical students’ early workplace experience could benefit the NHS
por: Oyekwe, George Chukwuemeka, et al.
Publicado: (2021)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
por: Wu, Mary Y, et al.
Publicado: (2023)

An alternative continuous positive airway pressure system for COVID-19 patients
por: Pfitzner, John, et al.
Publicado: (2020)

How interprofessional education could benefit the future of healthcare – medical students’ perspective
por: Choudhury, Regwaan Imtiaz, et al.
Publicado: (2020)

Delaying Renal Replacement Therapy Could Be Harmful in Patients with Acute Brain Injury
por: Chousterman, Benjamin G., et al.
Publicado: (2019)

Could Free Glutamic Acid in Processed Food be the Surprise Ingredient in Mood Disorders?
por: Samuels, Adrienne
Publicado: (2021)

Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients
por: Loor, Karina, et al.
Publicado: (2020)

“Please doctor, could you tell him that I love him?”: Letter from plastic surgeons at the COVID-19 warfront
por: Sallam, Davide, et al.
Publicado: (2020)

Could the Quick Sequential Organ Failure Assessment Predictive Accuracy Be Affected by Site of Infection?
por: Akinosoglou, Karolina, et al.
Publicado: (2020)

Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing?
por: Mouliou, Dimitra S., et al.
Publicado: (2022)

Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
por: Perret, Jennifer L., et al.
Publicado: (2022)

The effects of the COVID-19 pandemic on efficiency and airway management
por: Shackleford, Violet, et al.
Publicado: (2021)

Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? – Authors' reply
por: Yang, Huazhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1muog9d88606rf14ir9g6d0p28